ArticleInternational journal of endocrinology2025
Precision Screening for MetS: The Role of Derived Lipid Indicators in Chinese Populations.
Article in International journal of endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Metabolic syndrome (MetS) is a significant public health concern among middle-aged and elderly populations in China. This study evaluates the predictive value of four derived lipid indicators-lipid accumulation product (LAP), visceral adiposity index (VAI), triglyceride-glucose (TyG) index, and Chinese visceral adiposity index (CVAI) for MetS in Chinese adults aged ≥ 45 years. Data were sourced from the 2015 China Health and Retirement Longitudinal Study (CHARLS). Participants were classified according to the International Diabetes Federation (IDF), National Cholesterol Education Program (NCEP ATP III, 2001), and China's 2020 Guidelines for Type 2 Diabetes Prevention and Treatment. Multivariate logistic regression and ROC curve analyses assessed the predictive performance of these indicators. Results demonstrated that LAP and CVAI showed the highest predictive accuracy for MetS under the IDF criteria (AUC = 0.903), while LAP and TyG were most effective under the NCEP ATP III and China 2020 guidelines (AUC = 0.860). Subgroup analyses revealed sex- and age-specific variations in indicator effectiveness. This study suggests that derived indicators, particularly LAP and TyG, enhance the screening and management of MetS in middle-aged and elderly Chinese populations. These findings support the adoption of LAP and TyG in clinical practice to improve early detection and targeted intervention strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.